BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 19156118)

  • 1. [Medicamentous test for the screening of pharmacogenic risk of aminoglycoside ototoxicity].
    Abakarov MG; Magomedov MM; Belousov IuB; Gotovskiĭ MIu
    Vestn Otorinolaringol; 2008; (6):48-51. PubMed ID: 19156118
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Audiologic testing and molecular analysis of 12S rRNA in patients receiving aminoglycosides.
    Gürtler N; Schmuziger N; Kim Y; Mhatre AN; Jungi M; Lalwani AK
    Laryngoscope; 2005 Apr; 115(4):640-4. PubMed ID: 15805873
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rapid mass screening method and counseling for the 1555A-->G mitochondrial mutation.
    Usami S; Abe S; Shinkawa H; Inoue Y; Yamaguchi T
    J Hum Genet; 1999; 44(5):304-7. PubMed ID: 10496072
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aminoglycoside induced ototoxicity in patients with cystic fibrosis.
    Mulherin D; Fahy J; Grant W; Keogan M; Kavanagh B; FitzGerald M
    Ir J Med Sci; 1991 Jun; 160(6):173-5. PubMed ID: 1752740
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic susceptibility to aminoglycoside ototoxicity.
    Nguyen T; Jeyakumar A
    Int J Pediatr Otorhinolaryngol; 2019 May; 120():15-19. PubMed ID: 30743189
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A mutation in mitochondrial 12S rRNA, A827G, in Argentinean family with hearing loss after aminoglycoside treatment.
    Chaig MR; Zernotti ME; Soria NW; Romero OF; Romero MF; Gerez NM
    Biochem Biophys Res Commun; 2008 Apr; 368(3):631-6. PubMed ID: 18261986
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New developments in our understanding of ototoxicity.
    Roland PS
    Ear Nose Throat J; 2004 Sep; 83(9 Suppl 4):15-6; discussion 16-7. PubMed ID: 15543837
    [No Abstract]   [Full Text] [Related]  

  • 8. Aminoglycoside ototoxicity.
    Rizzi MD; Hirose K
    Curr Opin Otolaryngol Head Neck Surg; 2007 Oct; 15(5):352-7. PubMed ID: 17823553
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ototoxicity after use of neomycin eardrops is unrelated to A1555G point mutation in mitochondrial DNA.
    Yamasoba T; Tsukuda K
    J Laryngol Otol; 2004 Jul; 118(7):546-50. PubMed ID: 15318963
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Pathomorphological aspects of the action of aminoglycoside antibiotics on the acoustic analyzer].
    Zhuravskiĭ SG; Tomson VV; Tsvyleva ID; Ivanov AG
    Vestn Otorinolaringol; 2003; (2):55-60. PubMed ID: 12958868
    [No Abstract]   [Full Text] [Related]  

  • 11. Sensorineural hearing loss in patients with cystic fibrosis.
    Cheng AG; Johnston PR; Luz J; Uluer A; Fligor B; Licameli GR; Kenna MA; Jones DT
    Otolaryngol Head Neck Surg; 2009 Jul; 141(1):86-90. PubMed ID: 19559964
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ototoxicity of aminoglycoside antibiotics in infants and children.
    Assael BM; Parini R; Rusconi F
    Pediatr Infect Dis; 1982; 1(5):357-65. PubMed ID: 6760147
    [No Abstract]   [Full Text] [Related]  

  • 13. The role of routine hearing screening in children with cystic fibrosis on aminoglycosides: A systematic review.
    Farzal Z; Kou YF; St John R; Shah GB; Mitchell RB
    Laryngoscope; 2016 Jan; 126(1):228-35. PubMed ID: 26152803
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Ototoxicity of aminoglycoside antibiotics: an alternative in sight?].
    Ruppersberg JP
    HNO; 1997 Mar; 45(3):111-2. PubMed ID: 9417430
    [No Abstract]   [Full Text] [Related]  

  • 15. Efficacy of utilising patient self-report of auditory complaints to monitor aminoglycoside ototoxicity.
    Ramma LD; Ibekwe TS
    Int J Tuberc Lung Dis; 2012 Feb; 16(2):283. PubMed ID: 22236938
    [No Abstract]   [Full Text] [Related]  

  • 16. Progressive Hearing Loss among Patients with Cystic Fibrosis and Parenteral Aminoglycoside Treatment.
    Zettner EM; Gleser MA
    Otolaryngol Head Neck Surg; 2018 Nov; 159(5):887-894. PubMed ID: 29914288
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aminoglycoside ototoxicity susceptibility in cystic fibrosis.
    Mulrennan SA; Helm J; Thomas RB; Dodd M; Jones A; Webb K
    Thorax; 2009 Mar; 64(3):271-2. PubMed ID: 19252031
    [No Abstract]   [Full Text] [Related]  

  • 18. [Aminoglycosides, their ototoxic effect].
    de la Rosa-Gálvez A; Jáuregui-Renaud K; Hernández-Goribar M
    Gac Med Mex; 1998; 134(6):705-11. PubMed ID: 9927776
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aminoglycoside ototoxicity in Nicaraguan children: patient risk factors and mitochondrial DNA results.
    Saunders JE; Greinwald JH; Vaz S; Guo Y
    Otolaryngol Head Neck Surg; 2009 Jan; 140(1):103-7. PubMed ID: 19130971
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic and clinical features of sensorineural hearing loss associated with the 1555 mitochondrial mutation.
    Usami S; Abe S; Kasai M; Shinkawa H; Moeller B; Kenyon JB; Kimberling WJ
    Laryngoscope; 1997 Apr; 107(4):483-90. PubMed ID: 9111378
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.